[1] Ana I.O， Cláudia P， Bruno S， et al. Neuroprotective activity of hypericum perforatum and its major components[J]. Front. Plant Sci，2016，7：1004. [2] Loai B， Zohar K. Interactions between CYP3A4 and dietary polyphenols[J].Oxid Med Cell Longevity，2015；2015：854015. [3] Rajarshi B， Keyvan R， Raktim KG. Herb-drug interaction： The importance of communicating with primary care physicians[J].AMJ，2015；8(10)：315-319. [4] Sompon W， Virapong P. Cytochrome P450 enzyme mediated herbal drug interactions(part 1) [J]. EXCLI Journal，2014；13：347-391. [5] Colombo D， Lunardon L， Bellia G. Cyclosporine and herbal supplement interactions [J]. J Toxicology，2014；2014：145325. [6] 刘治军，刘宁，孙春华，等. 氟西汀和圣约翰草提取物对环孢素体外经CYP3A4代谢的影响[J].中国新药杂志，2009，18(2)：155-158. [7] Liu YN， Luo XM， Yang CX， et al. Impact of quercetin-induced changes in drug-metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats[J]. Mol Med Rep，2016 Oct；14(4)：3073-3085. [8] Vasudev K， Elke K， Michiel J， et al. Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics： towards personalized drug therapy[J]. Metabolomics，2017；13(1)：9. [9] Wang ZY， Chen M， Zhu LL， et al. Pharmacokinetic drug interactions with clopidogrel： updated review and risk management in combination therapy[J].Ther Clin Risk Manag，2015；11：449-467. [10] Zhang XL， Chen M， Zhu LL， et al. Therapeutic risk and benefits of concomitantly using herbal medicines and conventional medicines： from the perspectives of evidence based on randomized controlled trials and clinical risk management[J]. Evid Based Complement Alternat Med，2017；2017：9296404. [11] Andrew S， Karolina P， Harry H， et al. A review of the toxicity of HIV medications II： interactions with drugs and complementary and alternative medicine products[J]. J Med Toxicol，2015 Sep；11(3)：326-41. [12] Chandra P， Baltazar Z， Chung SS， et al. Nuclear receptors in drug metabolism， drug response and drug interactions[J]. Nucl Receptor Res2015 ；2. [13] Piscitelli SC， Burstein AH， Chaitt D， et al. Indinavir concentrations and St. John′s wort[J].Lancet，2000；355：547-548. [14] Misty MM， Michelle DL， Staci ML， et al. The role of dolutegravir in the management of HIV infection[J].Infect Drug Resist，2015；8：19–29. [15] Trana C， Toth G， Wijns W， et al. Clopidogrel undergoing percu-taneous coronary intervention：a single-center randomized open-label trial (St John’s Trial)[J].J Cardiovasc Transl Res，2013；6：411–414. [16] Lau WC， Welch TD， Shields T， et al. The effect of St John’s wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients： increased platelet inhibition by enhancement of CYP3A4 metabolic activity[J].J Cardiovasc Pharmacol，2011；57：86–93. [17] Jennifer C.F. L， Francesca G.Traditional Chinese medicine use among Chinese immigrant cancer patients[J].J Cancer Educ，2014 Mar；29(1)： 56–61. [18] Saud M.A， Rachel L.H， Elizabeth M.W. An assessment of the impact of herb-drug combinations used by cancer patients[J].BMC Complementary Altern Med，2016；16：393. [19] Wang Z， Wang L， Xia MM， et al. Pharmacokinetics interaction between imatinib and genistein in rats[J].BioMed Res Int， 2015；2015：368976. [20] Mathijssen RH， Verweij J， de Bruijn P， et al. Effects of St. John′s wort on irinotecan metabolism[J].J Natl Cancer Inst，2002；94：1247-1249. [21] Ma?gorzata B， Jaros?aw W. Progestogens in menopausal hormone therapy[J].Prz Menopauzalny，2015 Jun； 14(2)： 134-143. [22] Burstein AH， Horton RL， Dunn T， et al. Lack of effect of St. John′s wort on carbamazepine pharmacokinetics in healthy volunteers[J].Clin Pharmacol Ther，2000；68：605-612. [23] Damayanthi D， Nicole V， Joe M， et al. Effects of rifampin， cyclosporine A， and probenecid on the pharmacokinetic profile of canagliflozin， a sodium glucose co-transporter 2 inhibitor， in healthy participants[J].Int J Clin Pharmacol Ther，2015 Feb；53(2)：115-128. [24] Adrian IM， Fernando B， Elena VL，et al. Pemphigus foliaceus associated with hypericum perforatum[J].JAAD Case Rep，2016 Jul；2(4)：326-328.
